Jean LouisSelamMD

PubMed

• 8 citations
  Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
  M. Sternberg, Jocelyne M'bemba, P. Urios, Anne-Marie Borsos, Jean-Louis Selam, Jacques Peyroux, Gérard Slama> ;Clinical Biochemistry. 2016 Feb 1
• Evolution of diabetes insulin delivery devices.
  Selam, J. L.> ;J Diabetes Sci Technol. 2010 May
• Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial.
  Shaibani, A., Fares, S., Selam, J. L., Arslanian, A., Simpson, J., Sen, D., Bongardt, S.> ;J Pain.
• 70 citations
  Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type...
  Geremia B. Bolli, David Kerr, Reena Thomas, Elisabetta Torlone, Agnès Sola-Gazagnes, Ester Vitacolonna, Jean Louis Selam, Philip Home> ;Diabetes Care. 2009 Jul 1
• 7 citations
  Basal-bolus therapy with insulin detemir using the 303 algorithm in the US PREDICTIVE 303 trial
  Jean Louis Selam, Luigi F. Meneghini> ;Advances in Therapy. 2009 Mar 2
• Improving glycemic control with insulin detemir using the 303 Algorithm in insulin naïve patients with type 2 diabetes: a subgroup analysis of the US PREDICTIVE 303 st...
  Selam, J. L., Koenen, C., Weng, W., Meneghini, L.> ;Curr Med Res Opin. 2008 Jan
• 103 citations
  The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes – results of the randomized, controlled ...
  Luigi F. Meneghini, Christoph Koenen, Wayne Weng, Jean Louis Selam> ;Diabetes, Obesity & Metabolism. 2007 Nov 1
• Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, com...
  Dufaitre-Patouraux, L., Riveline, J. P., Renard, E., Melki, V., Belicar-Schaepelynck, P., Selam, J. L., Guerci, B., Millot, L., Brun, J. M., Fermon, C., Catargi, B., G...> ;Diabetes Metab. 2006 Nov
• Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptide-negative type 1 diabetes.
  Taverna, M. J., Selam, J. L., Slama, G.> ;J Clin Endocrinol Metab. 2005 Aug
• The T-786C and C774T endothelial nitric oxide synthase gene polymorphisms independently affect the onset pattern of severe diabetic retinopathy.
  Taverna, M. J., Elgrably, F., Selmi, H., Selam, J. L., Slama, G.> ;Nitric Oxide. 2005 Aug
• Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 mont...
  De Leeuw, I., Vague, P., Selam, J. L., Skeie, S., Lang, H., Draeger, E., Elte, J. W.> ;Diabetes Obes Metab. 2005 Jan
• Cyclic relationships between diabetic nephropathy and cardiovascular risk factors.
  Charles, M. A., Selam, J. L.> ;Metab Syndr Relat Disord. 2005
• 3 citations
  Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression.
  M. Arthur Charles, Jean-Louis Selam> ;Diabetes Care. 2004 May 1
• Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patie...
  Gin, H., Renard, E., Melki, V., Boivin, S., Schaepelynck-Bélicar, P., Guerci, B., Selam, J. L., Brun, J. M., Riveline, J. P., Estour, B., Catargi, B.> ;Diabetes Metab. 2003 Dec
• 19 citations
  Successful Treatment of Insulin Allergy in a Type 1 Diabetic Patient by Means of Constant Subcutaneous Pump Infusion of Insulin
  Agnès Sola-Gazagnes, Catherine Pecquet, Régis Radermecker, Laurence Piétri, F. Elgrably, Géérard Slama, Jean-Louis Selam> ;Diabetes Care. 2003 Oct 1
• Effects of dipeptide administration on hypoglycaemic counterregulation in type 1 diabetes.
  M'bemba, J., Cynober, L., de Bandt, P., Taverna, M., Chevalier, A., Bardin, C., Slama, G., Selam, J. L.> ;Diabetes Metab. 2003 Sep
• 17 citations
  Inhaled insulin for the treatment of diabetes: projects and devices.
  Jean Louis Selam> ;Expert Opinion on Pharmacotherapy. 2003 Aug 1
• Type I diabetes in adults and children
  Jean Louis Selam> ;La Revue Du Praticien. 2003 May 1
• Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions.
  Djakouré-Platonoff C, Radermercker R, Reach G, Slama G, Selam JI> ;Diabetes Metab.. 2003-04-01
• Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolu...
  Vague, P., Selam, J. L., Skeie, S., De Leeuw, I., Elte, J. W., Haahr, H., Kristensen, A., Draeger, E.> ;Diabetes Care. 2003 Mar
• eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy.
  Taverna, M. J., Sola, A., Guyot-Argenton, C., Pacher, N., Bruzzo, F., Chevalier, A., Slama, G., Reach, G., Selam, J. L.> ;Diabet Med. 2002 Mar
• Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy.
  Taverna, M. J., Sola, A., Guyot-Argenton, C., Pacher, N., Bruzzo, F., Slama, G., Reach, G., Selam, J. L.> ;Diabetologia. 2002 Mar
• Inhaled insulin: clinical results in type 2 diabetic patients.
  Selam, J. L.> ;Diabetes Metab. 2001 Nov
• Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus.
  Boulton, A. J., Selam, J. L., Sweeney, M., Ziegler, D.> ;Diabetologia. 2001 Oct
• Efficacy and tolerance of intranasal insulin administered during 4 months in severely hyperglycaemic Type 2 diabetic patients with oral drug failure: a cross-over study.
  Lalej-Bennis, D., Boillot, J., Bardin, C., Zirinis, P., Coste, A., Escudier, E., Chast, F., Peynegre, R., Selam, J. L., Slama, G.> ;Diabet Med. 2001 Aug
• Join now to see all